Elevated serum levels of TNFSF13 have been reported in oral cavity cancers (33), and are correlated with increased serum TNF levels, angiogenesis and poor prognosis in multiple myeloma (34). This evidence concerns the gene TNFSF13 and plasma cell myeloma.